Concepedia

Author

Paweł Gut

Poznan University of Medical SciencesORCID

Also Known As

P Gut, P. GUT, P. Gut, PAWEŁ GUT, Pawel Gut, Paweł Gut

90

Publications

892

Citations

16

H-Index

56

Concepts

All Affiliations

Poznan University of Medical SciencesMedical University of WarsawNational Centre for Nuclear ResearchMedical University of Silesia
PG

About

Paweł Gut is an author at Poznan University of Medical Sciences specializing in medicine, oncology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

148

2

Health Sciences

2

2

67

3

Natural Sciences

1

1

11

4

Public Health

1

1

10

5

Allergy

1

1

11

Paweł Gut

×

18

Publications

498

Citations

12

H-Index

YearCitations

Chromogranin A – unspecific neuroendocrine marker. Clinical utility and potential diagnostic pitfalls

Paweł Gut, Agata Czarnywojtek, Jakub Fischbach,

Archives of Medical Science

2016

138

Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

Jolanta Kunikowska, Anna Zemczak, Maciej Kołodziej,

European Journal of Nuclear Medicine and Molecular Imaging

2020

53

The c.470 T > C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Great Poland population

Marta Kaczmarek-Ryś, Katarzyna Ziemnicka, Szymon Hryhorowicz,

Hereditary Cancer in Clinical Practice

2015

36

Growth hormone–secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog 90Y-DOTATATE: case report

Joanna Waligórska‐Stachura, Paweł Gut, Nadia Sawicka‐Gutaj,

Journal of neurosurgery

2015

36

A prospective randomized trial: A comparison of the analgesic effect and toxicity of 153Sm radioisotope treatment in monotherapy and combined therapy including local external beam radiotherapy (EBRT) among metastatic Castrate Resistance prostate cancer (m

Maciej Bączyk, Piotr Milecki, Marcin Pisarek,

Neoplasma

2013

31

Management of the hormonal syndrome of neuroendocrine tumors

Paweł Gut, Joanna Waligórska‐Stachura, Agata Czarnywojtek,

Archives of Medical Science

2016

29

Radioiodine therapy and Graves’ disease – Myths and reality

Maria Teresa Płazińska, Nadia Sawicka‐Gutaj, Agata Czarnywojtek,

PLoS ONE

2020

26

Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer — comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen

Kosma Woliński, Jarosław Kaznowski, Aleksandra Klimowicz,

Endokrynologia Polska

2017

24

The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET

Anna Zemczak, Paweł Gut, Dariusz Pawlak,

International Journal of Endocrinology

2021

18

Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6‑month follow‑up

Agata Czarnywojtek, Krzesisława Komar-Rychlicka, Małgorzata Zgorzalewicz-Stachowiak,

Polskie Archiwum Medycyny Wewnętrznej

2016

16

Page 1